Marjon A. de Boer

2.6k total citations
112 papers, 1.5k citations indexed

About

Marjon A. de Boer is a scholar working on Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Marjon A. de Boer has authored 112 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Obstetrics and Gynecology, 53 papers in Pediatrics, Perinatology and Child Health and 38 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Marjon A. de Boer's work include Pregnancy and preeclampsia studies (41 papers), Preterm Birth and Chorioamnionitis (24 papers) and Pregnancy and Medication Impact (15 papers). Marjon A. de Boer is often cited by papers focused on Pregnancy and preeclampsia studies (41 papers), Preterm Birth and Chorioamnionitis (24 papers) and Pregnancy and Medication Impact (15 papers). Marjon A. de Boer collaborates with scholars based in Netherlands, Australia and United States. Marjon A. de Boer's co-authors include Koop Lammertsma, Christianne J.M. de Groot, Gert Jan Fleuren, Ben W. Mol, Dick Oepkes, Ekaterina S. Jordanova, E. J. T. Verweij, Linda Schoonmade, Martijn W. Heymans and Caroline J. Bax and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Gut.

In The Last Decade

Marjon A. de Boer

103 papers receiving 1.5k citations

Peers

Countries citing papers authored by Marjon A. de Boer

Since Specialization

Citations

This map shows the geographic impact of Marjon A. de Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjon A. de Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjon A. de Boer more than expected).

Fields of papers citing papers by Marjon A. de Boer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjon A. de Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjon A. de Boer. The network helps show where Marjon A. de Boer may publish in the future.

Co-authorship network of co-authors of Marjon A. de Boer

This figure shows the co-authorship network connecting the top 25 collaborators of Marjon A. de Boer. A scholar is included among the top collaborators of Marjon A. de Boer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjon A. de Boer. Marjon A. de Boer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improved neonatal outcome following induction of labour using 25 µg versus 50 µg oral Misoprostol: A retrospective, comparative cohort study 2025 ·Journal of Gynecology Obstetrics and Human Reproduction ·(unknown), Christianne J.M. de Groot, Roel de Heus, Marjon A. de Boer	1
2	Cervical pessary versus vaginal progesterone in women with a multiple pregnancy and a short cervix: A randomised controlled trial 2025 ·PLoS Medicine ·(unknown), (unknown), (unknown), Bouchra Koullali, (unknown), (unknown), (unknown), J. van Drongelen, Marjon A. de Boer, W.M. van Baal, Karlijn C. Vollebregt, (unknown), Sanne J. Gordijn, Marieke Sueters, Lia D. E. Wijnberger, Martijn A. Oudijk, Ben W. Mol, (unknown), Eva Pajkrt	0
3	Optimal treatment for women with acute hypertension in pregnancy; a randomized trial comparing intravenous labetalol versus nicardipine 2024 ·Pregnancy Hypertension ·(unknown), Marjon A. de Boer, Benjamin Gravesteijn, Wietske Hermes, Wessel Ganzevoort, Frank van Bel, Ben W. Mol, Christianne J.M. de Groot	0
4	The value of a mobile educative Application additional to Standard counselling on aspirin Adherence in Pregnancy: the ASAP study, a randomised controlled trial 2024 ·SHILAP Revista de lepidopterología ·(unknown), Marjon A. de Boer, (unknown), (unknown), Marijke Melles, Johanna I.P. de Vries, Christianne J.M. de Groot	1
5	Concentrations of subcutaneously administered belimumab in human breast milk of a woman with systemic lupus erythematosus: a case report 2024 ·Lupus Science & Medicine ·(unknown), Marjon A. de Boer, Mirjam M. van Weissenbruch, (unknown), Theo Rispens, Alexandre E. Voskuyl, Irene E. M. Bultink	3
6	Considering multifetal pregnancy reduction in triplet pregnancies: do we forget the emotional impact on fathers? A qualitative study from The Netherlands 2024 ·Human Reproduction ·(unknown), (unknown), Marjon A. de Boer, Christianne J.M. de Groot, Eva Pajkrt, Birit F. P. Broekman, Maria G. van Pampus	1
7	Methods of induction of labor in women with obesity: A secondary analysis of two multicenter randomized controlled trials 2024 ·Acta Obstetricia Et Gynecologica Scandinavica ·(unknown), (unknown), (unknown), Kitty W.M. Bloemenkamp, Mieke Ten Eikelder, Roel de Heus, Marta Jozwiak, Judith Kooiman, Ben W. Mol, Corine Verhoeven, Marjon A. de Boer	5
8	Multicentre study and systematic review: Allopurinol exposure during pregnancy 2024 ·Alimentary Pharmacology & Therapeutics ·(unknown), Melek Simsek, Marjon A. de Boer, Dirk P. van Asseldonk, (unknown), (unknown), Lennard P. L. Gilissen, Robert J. Verburg, (unknown), Bindia Jharap, Johan Kuijvenhoven, Bas Oldenburg, (unknown), Mette Julsgaard, Nanne K.H. de Boer	10
9	Vaginal microbiota and spontaneous preterm birth in pregnant women at high risk of recurrence 2024 ·Heliyon ·(unknown), (unknown), (unknown), Rik van Eekelen, Sébastien Matamoros, Marjon A. de Boer, Martijn A. Oudijk, Carrie Ris‐Stalpers, Piet Cools, Paul H. M. Savelkoul, Rebecca C. Painter, Robin van Houdt	6
10	Cervical pessary versus vaginal progesterone in women with a singleton pregnancy, a short cervix, and no history of spontaneous preterm birth at less than 34 weeks’ gestation: open label, multicentre, randomised, controlled trial 2024 ·BMJ ·(unknown), (unknown), (unknown), Bouchra Koullali, (unknown), (unknown), (unknown), W.M. van Baal, (unknown), J. van Drongelen, Karlijn C. Vollebregt, M. A. Müller, (unknown), Sanne J. Gordijn, (unknown), Martijn A. Oudijk, Marjon A. de Boer, Ben W. Mol, (unknown), Eva Pajkrt	5
11	A new approach to drug intravenous compatibility research: the case of obstetric parenteral drugs 2023 ·European Journal of Hospital Pharmacy ·(unknown), (unknown), Marjon A. de Boer, Abraham J. Wilhelm, (unknown), Pierre M. Bet	2
12	Uterine Fibroids Causing Preterm Birth: A New Pathophysiological Hypothesis on the Role of Fibroid Necrosis and Inflammation 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Ekaterina S. Jordanova, Emiel D. Post Uiterweer, Christianne J.M. de Groot, Marjon A. de Boer, Judith A.F. Huirne	6
13	Added prognostic value of Doppler ultrasound for adverse perinatal outcomes: A pooled analysis of three cohort studies 2022 ·Australian and New Zealand Journal of Obstetrics and Gynaecology ·(unknown), (unknown), Wentao Li, Wessel Ganzevoort, Marjon A. de Boer, (unknown), Özhan Turan, Patrick M. Bossuyt, Ben W. Mol, Daniel L. Rolnik	2
14	Long-term follow-up of children exposed in-utero to progesterone treatment for prevention of preterm birth: study protocol of the AMPHIA follow-up 2021 ·BMJ Open ·(unknown), (unknown), Aleid G. van Wassenaer‐Leemhuis, Martijn J.J. Finken, Cornelieke S.H. Aarnoudse-Moens, Jaap Oosterlaan, Anneloes L. van Baar, Tessa J. Roseboom, Arianne Lim, Madelon van Wely, Marjon A. de Boer, Rebecca C. Painter, Eva Pajkrt, Martijn A. Oudijk, Janneke van ’t Hooft	2
15	Cerebroplacental ratio in predicting adverse perinatal outcome: a meta‐analysis of individual participant data 2020 ·BJOG An International Journal of Obstetrics & Gynaecology ·(unknown), (unknown), Martijn W. Heymans, Wessel Ganzevoort, Linda Schoonmade, (unknown), Ben W. Mol, Christianne J.M. de Groot, (unknown), Marjon A. de Boer, (unknown)	30
16	Cardiovascular risk after hypertensive disorders of pregnancy in women with and without inheritable Thrombophilia 2020 ·Hypertension in Pregnancy ·(unknown), Carolien N. H. Abheiden, Anouk Bokslag, Abel Thijs, Christianne J.M. de Groot, Johanna I.P. de Vries, Marjon A. de Boer	1
17	Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction 2020 ·JAMA Network Open ·Anouk Pels, Jan Derks, (unknown), J. van Drongelen, Marjon A. de Boer, Hans Duvekot, (unknown), Jim van Eyck, Salwan Al‐Nasiry, Marieke Sueters, Marinka S. Post, Wes Onland, Aleid G. Leemhuis, Christiana Naaktgeboren, Janus Christian Jakobsen, Christian Gluud, Ruben G. Duijnhoven, A. Titia Lely, Sanne J. Gordijn, Wessel Ganzevoort, (unknown)	80
18	Risk of preterm birth after prior term cesarean 2019 ·BJOG An International Journal of Obstetrics & Gynaecology ·(unknown), (unknown), (unknown), (unknown), Martijn A. Oudijk, Christianne J.M. de Groot, Ben W. Mol, Marjon A. de Boer	23
19	Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta‐analysis 2017 ·Ultrasound in Obstetrics and Gynecology ·(unknown), Marjon A. de Boer, Martijn W. Heymans, Linda Schoonmade, Patrick M. Bossuyt, Ben W. Mol, Christianne J.M. de Groot, Caroline J. Bax	143
20	OP0310 Pregnancy outcome in women with systemic lupus erythematosus, a multicenter cohort-study 2017 ·Annals of the Rheumatic Diseases ·(unknown), Carolien N. H. Abheiden, (unknown), Jacob M. van Laar, R. H. W. M. Derksen, (unknown), Alexandre E. Voskuyl, A. Titia Lely, Marjon A. de Boer, Jip de Vries, Ruth Fritsch‐Stork	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact